Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · January 23, 2024

Inhaled Recombinant GM-CSF Reduces the Need for Whole Lung Lavage and Improves Gas Exchange in Patients With Autoimmune Pulmonary Alveolar Proteinosis

The European Respiratory Journal


Additional Info

Disclosure statements are available on the authors' profiles:

The European Respiratory Journal
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients
Eur. Respir. J. 2024 Jan 04;63(1)2301233, I Campo, BC Carey, E Paracchini, Z Kadija, A De Silvestri, G Rodi, M De Amici, C Torre, M Zorzetto, M Griese, F Meloni, AG Corsico, BC Trapnell, F Mariani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading